✦ LIBER ✦

Phase III results in Genotype 1 naïve patients: predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin

✍ Scribed by Paul Y. Kwo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III results of Boceprevir in treat

✍ Michael P. Manns; Antoaneta A. Markova; Beatriz Calle Serrano; Markus Cornberg 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Su1060 Faldaprevir Plus Pegylated Interf

✍ Asselah, Tarik; Jensen, Donald M.; Foster, Graham; Sulkowski, Mark; Ouzan, Denis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Faldaprevir combined with pegylated inte

✍ Sulkowski, Mark S.; Asselah, Tarik; Lalezari, Jacob; Ferenci, Peter; Fainboim, H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

P1120 PREDICTION OF SUSTAINED VIROLOGIC

✍ Zeuzem, S.; Demasi, R.; Foster, G.R.; Buti, M.; Baldini, A.; Luo, D.; Witek, J.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Cost-effectiveness of telaprevir in comb

✍ Cure, Sandrine; Bianic, Florence; Gavart, Sandra; Curtis, Steve; Lee, Seina; Dus 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 841 KB

Cost-effectiveness of telaprevir in comb

✍ Cure, Sandrine; Bianic, Florence; Gavart, Sandra; Curtis, Steve; Lee, Seina; Dus 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 491 KB